Cargando…
Hybridoma-derived neutralizing monoclonal antibodies against Beta and Delta variants of SARS-CoV-2 in vivo
Neutralizing monoclonal antibodies (mAb) are a major therapeutic strategy for the treatment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. The continuous emergence of new SARS-CoV-2 variants worldwide has increased the urgency for the development of new mAbs. In this stud...
Autores principales: | Wang, Qianran, Peng, Lu, Nie, Yanqiu, Shu, Yanni, Zhang, Huajun, Song, Zidan, Li, Yufeng, Hu, Hengrui, Li, Liushuai, Wang, Xi, Liu, Jia, Li, Jiang, Shi, Zhengli, Deng, Fei, Guo, Yu, Zhou, Yiwu, Yan, Bing, Hu, Zhihong, Wang, Manli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wuhan Institute of Virology, Chinese Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803610/ https://www.ncbi.nlm.nih.gov/pubmed/36596381 http://dx.doi.org/10.1016/j.virs.2022.12.007 |
Ejemplares similares
-
Infection of human sweat glands by SARS-CoV-2
por: Liu, Jia, et al.
Publicado: (2020) -
Human IgA Monoclonal Antibodies That Neutralize Poliovirus, Produced by Hybridomas and Recombinant Expression
por: Puligedda, Rama Devudu, et al.
Publicado: (2020) -
A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus
por: Du, Ruikun, et al.
Publicado: (2017) -
Generation of the first monoclonal antibody using mouse hybridomas
por: Falini, Brunangelo
Publicado: (2022) -
The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro
por: Wang, Xi, et al.
Publicado: (2020)